Biofil Chemicals Intrinsic Value
Biofil Chemicals (BIOFILCHEM) median intrinsic value is ₹26.25 from 9 valuation models (range ₹17–₹40), vs current price ₹31.55 — -16.8% downside (Trading Above Median Value), margin of safety -20.2%. Also explore BIOFILCHEM share price history to track price trends across different timeframes.
BIOFILCHEM Valuation Methods Summary — DCF, Graham Number & P/E
Biofil Chemicals intrinsic value across 9 models vs current price ₹31.55 — upside/downside and value range per method. For current market price and key ratios, visit Biofil Chemicals stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹37.40 | ₹29.92 - ₹44.88 | +18.5% | EPS: ₹1.70, Sector P/E: 22x |
| Book Value Method | asset | ₹23.75 | ₹21.38 - ₹26.13 | -24.7% | Book Value/Share: ₹11.88, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹40.00 | ₹36.00 - ₹44.00 | +26.8% | Revenue/Share: ₹20.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹25.00 | ₹22.50 - ₹27.50 | -20.8% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹16.98 | ₹13.58 - ₹20.38 | -46.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹27.20 | ₹24.48 - ₹29.92 | -13.8% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹26.60 | ₹23.94 - ₹29.26 | -15.7% | Revenue Growth: 8.6%, Adj P/E: 15.6x |
| ROE Based Valuation | profitability | ₹26.25 | ₹23.62 - ₹28.88 | -16.8% | ROE: 15.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹21.31 | ₹19.18 - ₹23.44 | -32.5% | EPS: ₹1.70, BVPS: ₹11.88 |
BIOFILCHEM Intrinsic Value vs Market Price — All Valuation Models
Biofil Chemicals fair value range ₹17–₹40 vs current market price ₹31.55 across 9 valuation models. Browse BIOFILCHEM balance sheet details for revenue, profit, balance sheet and cash flow data.
BIOFILCHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Biofil Chemicals median intrinsic value ₹26.25, current price ₹31.55 — Trading Above Median Value by 16.8%, margin of safety -20.2%.
What is the intrinsic value of BIOFILCHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹26.25 (median value). With the current market price of ₹31.55, this represents a -16.8% variance from our estimated fair value.
The valuation range spans from ₹16.98 to ₹40.00, indicating ₹16.98 - ₹40.00.
Is BIOFILCHEM undervalued or overvalued?
Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above median value by approximately 16.8%.
BIOFILCHEM Financial Health — Key Ratios vs Industry Benchmarks
Biofil Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 15.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.63x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BIOFILCHEM Cash Flow Quality — Operating & Free Cash Flow
Biofil Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |